MeSH tree: C06.552.241.519
Retatrutide, an experimental weight-loss drug that could compete against blockbusters Wegovy and Zepbound, may work wonders for obese folks with liver disease, new research shows.
Nov 15, 2023
0
49
New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, shows that treating rheumatoid arthritis with hydroxychloroquine (HCQ) reduced the risk of nonalcoholic fatty liver disease, ...
Nov 7, 2023
0
64
Teens from low-income families experiencing food insecurity are developing the most common form of liver disease twice as often as those who have easier access to food, likely because they rely on low-cost, ultra-processed ...
Nov 7, 2023
0
63
An international clinical trial involving Birmingham Professor Phil Newsome identified a promising target for patients with non-alcoholic steatohepatitis (NASH), as reported in a paper published yesterday (Nov. 6) in Nature ...
Nov 7, 2023
0
53
A study spearheaded by Oregon State University has shown why certain polyunsaturated fatty acids work to combat a dangerous liver condition, opening a new avenue of drug research for a disease that currently has no FDA-approved ...
Oct 25, 2023
0
69
A growing body of research is drawing attention to health threats posed by human-made chemicals called "forever chemicals," which are targeted by a new California law requiring manufacturers to reduce their use in food packaging ...
Oct 18, 2023
0
61
A new study by QIMR Berghofer published in the Medical Journal of Australia has highlighted the critical need for doctors to be more vigilant with early detection and monitoring of liver complications in patients with diabetes ...
Oct 17, 2023
0
44
Fatty liver disease is exploding globally, affecting as many as 30% of people in Western countries. Apart from alcohol, obesity and diabetes are among the most dominant risk factors.
Oct 2, 2023
0
47
A severe form of fatty liver disease called nonalcoholic steatohepatitis (NASH) is the leading cause of liver transplantation, but there are few treatment options and currently no medications. In a new study, Yale researchers ...
Sep 27, 2023
0
85
Hepatic fibrosis occurs when scar tissue replaces damaged cells in the liver. Over time, accumulating scarring distorts the liver, interferes with its blood supply and may progressively lead to worsening consequences, from ...
Sep 27, 2023
0
42
